Creatine makes dendritic cells more effective at triggering immune responses against cancer. This leads to stronger anti-tumor immune attacks and causes tumors to shrink.
From A New Study Just Linked Creatine To Cancer · videoSee the scientific wording
Creatine enhances dendritic cell function, leading to improved anti-tumor immune responses and tumor regression.
Correlational — new studies may shift this
ObservationalOne moderate-quality study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
Cohort StudyHuman2026
This study shows that giving creatine to immune cells called dendritic cells makes them more active and better at training T cells to kill cancer, and in mice, creatine helped shrink tumors.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Dendritic cells are immune cells that teach T cells to attack cancer. When activated, they bring in creatine from outside. Creatine helps them store energy. This stored energy keeps important signals inside the cell working properly, allowing the cell to produce molecules that activate T cells. These T cells then go into tumors and kill cancer cells, shrinking the tumor.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Creatine makes dendritic cells more effective at triggering immune responses against cancer. This leads to stronger anti-tumor immune attacks and causes tumors to shrink.
Mechanism
1 studyCreatine gives dendritic cells extra energy storage, which helps them stay active and teach T cells to attack tumors. The energized dendritic cells produce more activation signals, leading to stronger T cell responses that shrink tumors.
Dendritic cells are immune cells that teach T cells to attack cancer. When activated, they bring in creatine from outside. Creatine helps them store energy. This stored energy keeps important signals inside the cell working properly, allowing the cell to produce molecules that activate T cells. These T cells then go into tumors and kill cancer cells, shrinking the tumor.
Dendritic cells increase production of the creatine transporter on their surface after receiving an activation signal from molecules like those from bacteria or viruses.
The creatine transporter takes up creatine from the surrounding environment into the dendritic cell.
Inside the cell, creatine is converted to phosphocreatine by the enzyme creatine kinase, creating a reserve of high-energy phosphate groups.
When the cell uses energy, phosphocreatine donates its phosphate to regenerate ATP, maintaining high ATP levels and preventing energy depletion.
Sustained ATP levels allow the NF-κB signaling pathway to remain active, leading to the phosphorylation of proteins that release NF-κB so it can move into the nucleus.
Inside the nucleus, NF-κB turns on genes for costimulatory molecules like CD80 and CD86, and for cytokines like TNF-α, IL-6, and IL-1β.
The dendritic cell now displays these costimulatory molecules and releases cytokines, making it highly effective at activating naive CD8+ T cells that recognize tumor antigens.
Activated CD8+ T cells proliferate, produce IFN-γ and other effector molecules, and infiltrate the tumor, where they kill cancer cells and cause tumor regression.
Evidence from Studies
Last searched 2mo ago
Supporting (1)
Community contributions welcome
Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
This study shows that giving creatine to immune cells called dendritic cells makes them more active and better at training T cells to kill cancer, and in mice, creatine helped shrink tumors.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Randomized Controlled Trials on Creatine Supplementation and Cancer Immune Responses
Comprehensive search of RCTs in humans comparing creatine supplementation to placebo or no treatment, measuring dendritic cell function (e.g., activation markers, cytokine production), anti-tumor immune responses (e.g., T cell activity), and tumor regression (e.g., tumor size reduction, survival).
Double-Blind Randomized Placebo-Controlled Trial of Creatine Supplementation in Cancer Patients
Randomized, double-blind, placebo-controlled trial in cancer patients (e.g., with solid tumors) receiving creatine (e.g., 5g/day) versus placebo for a defined period (e.g., 6 months). Primary outcomes: dendritic cell activation markers (e.g., CD80, CD86 expression), secondary outcomes: tumor size by imaging, overall survival.
Prospective Cohort Study of Creatine Supplement Use and Cancer Outcomes
Prospective cohort of adults with cancer, with regular assessment of creatine supplement use (dose, duration), measurement of immune biomarkers, and tracking of tumor progression and survival over several years.
In Vitro Study of Creatine Effects on Dendritic Cell Function and T Cell Activation
Isolate dendritic cells from human or mouse blood, treat with creatine at various concentrations, measure maturation markers (e.g., MHC-II, costimulatory molecules), cytokine production, and ability to activate T cells in co-culture. Also assess effect on tumor cell killing in vitro.